Compound ID | 1130
Synonym(s): GV118819
Class: Beta-lactam
| Spectrum of activity: | Gram-positive |
| Details of activity: | Orally available prodrug ester of GV104326, improved activity against gram positive pathogens. |
| Description: | Hammond.S,M., et al. "GV118819 an orally absorbed prodrug ester of the tribactam GV104326"" Program and Abstracts of the 32st Intersci. Conf. on Antimicrob. Agents Chemother. No. 130. |
| Institute where first reported: | GlaxoSmithKline |
| Year first mentioned: | 1992 |
| Highest developmental phase: | Phase 2 |
| Development status: | Inactive |
| Reason Dropped: | Discontinued in 1999 |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/6918217 |
| Guide to Pharmacology: | sanfetrinem cilexetil |
| Citation: |